Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Evora
- Development stage
- Unknown
- Lead developer
- Oragenics
- Modality
- Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Evora is a line of oral care probiotics designed to support dental and gum health. It utilizes the ProBiora3 probiotic blend, which consists of three naturally occurring strains of beneficial bacteria: *Streptococcus oralis* KJ3, *Streptococcus rattus* JH145, and *Streptococcus uberis* KJ2. These strains work by colonizing the mouth and crowding out pathogenic bacteria that cause tooth decay, gum disease, and bad breath. Originally developed by Oragenics, the product line was sold to ProBiora Health in 2016. The product is marketed as a consumer probiotic for maintaining oral hygiene and promoting a healthy balance of oral flora.
- Brand names
- EvoraEvoraPlusEvoraKidsEvoraPetEvoraPro
- Other names
- ProBiora3ProBiora-3ProBiora 3
Beyond the preview
Go deeper on Evora.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Evora.